Skip to main
IRTC

iRhythm Technologies (IRTC) Stock Forecast & Price Target

iRhythm Technologies (IRTC) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 50%
Buy 42%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

iRhythm Holdings is a digital healthcare company that focuses on providing ambulatory cardiac monitoring services. Its Zio System, which combines a patch-based wearable biosensor and proprietary software, allows for quicker and more efficient diagnosis of arrhythmias. With a strong track record of revenue growth and potential upside drivers such as international expansion and new products, this analyst believes that iRhythm has a bright future ahead with the potential for double-digit revenue growth and profitability in the coming years. However, risks include competition and reimbursement developments, and investors should carefully monitor these factors.

Bears say

iRhythm Holdings is currently facing multiple headwinds, including potential downward pressure on commercial reimbursement rates, competitive pressure from existing players, and potential underwhelming performance of key product launches, all of which could hinder future revenue growth and profitability. Additionally, the company is facing potential regulatory risks from FDA warnings or settlement payments. While the company's Zio system has shown promising growth, there is uncertainty surrounding the launch of their upcoming ZioMCT product. As a result, the negative outlook for this stock is rooted in concerns about the company's ability to maintain its growth trajectory and meet its long-term financial targets.

iRhythm Technologies (IRTC) has been analyzed by 12 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 42% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About iRhythm Technologies (IRTC) Forecast

Analysts have given iRhythm Technologies (IRTC) a Buy based on their latest research and market trends.

According to 12 analysts, iRhythm Technologies (IRTC) has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $183, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $183, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

iRhythm Technologies (IRTC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.